Ray Ujjwayini, Dutta Soma, Khan Aftab
Department of Microbiology, Apollo Gleneagles Hospitals, Kolkata, West Bengal, India.
Department of Cardiology, Apollo Gleneagles Hospitals, Kolkata, West Bengal, India.
J Glob Infect Dis. 2021 Nov 9;14(1):38-40. doi: 10.4103/jgid.jgid_67_21. eCollection 2022 Jan-Mar.
The use of cardiovascular implantable electronic devices (CIED) is associated with improved quality of life and decreased fatal outcomes in patients with cardiac dysfunctions. As with all foreign devices that are inserted or implanted in the body, CIED also carries the risk of device-related infections. Infections account for <2% of the complications associated with CIED, and only about 2% of these are secondary to a fungal pathogen. The first case of endocarditis secondary to a transvenous pacing lead was reported in the 1980s, and a limited number of cases have been documented in the literature since then. endocarditis is a highly fatal disease and establishing the diagnosis sufficiently early is challenging. We here report a case of endocarditis secondary to permanent pacemaker insertion which was successfully treated following the establishment of the diagnosis using imaging studies and galactomannan assay.
心血管植入式电子设备（CIED）的使用与心脏功能障碍患者生活质量的改善及致命结局的减少相关。与所有植入体内的外来设备一样，CIED也存在与设备相关感染的风险。感染占CIED相关并发症的比例不到2%，其中仅约2%继发于真菌病原体。首例经静脉起搏导线继发的心内膜炎于20世纪80年代被报道，自那时起文献中记录的病例数量有限。心内膜炎是一种高致命性疾病，尽早确诊具有挑战性。我们在此报告一例永久起搏器植入继发的心内膜炎病例，该病例在通过影像学检查和半乳甘露聚糖检测确诊后得到了成功治疗。
